Items Tagged ‘plasma drug concentrations’

July 15, 2014 · Leave a Comment

Genome-Wide Associations of Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations

By Center for Individualized Medicine Center for Individualized Medicine (@samuelsmith5209)

    Published in the British Journal of Clinical Pharmacology, a team of researchers from the Mayo Clinic, led by the director of the Center for Individualized Medicine’s Pharmacogenomics Program, Richard Weinshilboum, M.D., applied a genome-wide association study (GWAS) to identify genetic factors that contribute to variation in plasma concentrations of Citalopram (CT) or escitalopram (S-CT), and […]

View full entry Comment on this

Tags: center for individualized medicine, citalopram, DNA, DNA Sequencing, dna test, DNA Testing, escitalopram, gene sequencing, genetic, Genetics, genome, genome science


March 13, 2014 · Leave a Comment

Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations: Genome-Wide Associations

By Mystery User

A recently published article in the area of Pharmacogenomics set out to identify genetic factors in Citalopram (CT) and escitalopram (S-CT), which are among the most widely prescribed serotonin reuptake inhibitors (SSRIs) used to treat Major Depressive Disorder (MDD), that contribute to variation in plasma concentrations of CT or S-CT and their metabolites in MDD patients treated […]

View full entry Comment on this

Tags: citalopram, dna test, DNA Testing, escitalopram, gene sequencing, genome science, genome-wide association studies, genomic medicine, genomics, individualized medicine, major depressive disorder, personal genomics


Contact Us · Privacy Policy